🇺🇸 FDA
Patent

US 9393305

Etanercept formulations stabilized with xylitol

granted A61KA61K38/17A61K38/1793

Quick answer

US patent 9393305 (Etanercept formulations stabilized with xylitol) held by Coherus BioSciences, Inc. expires Mon Jul 14 2036 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Coherus BioSciences, Inc.
Grant date
Tue Jul 19 2016 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jul 14 2036 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
3
CPC classes
A61K, A61K38/17, A61K38/1793, A61K38/191, A61K39/39591